Geneva, Feb. 2 -- International Clinical Trials Registry received information related to the study (ChiCTR2600117002) titled 'Prospective randomized controlled study of the timing of vasopressin in children with complex right heart disease after surgery' on Jan. 19.
Study Type: Interventional study
Study Design:
Parallel
Primary Sponsor: Fuwai Hospital, Chinese Academy of Medical Science
Condition:
congenital heart disease
Intervention:
Preventive Use Group:The measured SRVI < 1200 directly initiates the use of vasopressin
Recruitment Status: Not Recruiting
Phase: 0
Date of First Enrollment: 2022-12-14
Target Sample Size: Preventive Use Group:150;Traditional Use Group:150;
Countries of Recruitment:
China
To know more, vi...